Clinical trial
Pilot Study Prok-Idm: Interest of Dosage of Prokinecitine in Acute Myocardial Infarction
NCT02021487 is registered in ClinicalTrials.gov with University Hospital, Strasbourg, France as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pilot Study Prok-Idm: Interest of Dosage of Prokinecitine in Acute Myocardial Infarction
- Lead sponsor
- University Hospital, Strasbourg, France
- Phase
- Observational
- Overall status
- Terminated
- Start date
- November 30, 2013
- Completion date
- February 28, 2019
- Enrollment
- 172 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
st elevatation myocardial infarction (stemi)